Liver disorders in inflammatory bowel disease

Gastroenterology Research and Practice

Volumn , Issue , 2012, Pages

  Uko, Victor ^a   Thangada, Suraj ^a   Radhakrishnan, Kadakkal ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; SALAZOSULFAPYRIDINE;

BUDD CHIARI SYNDROME; CHOLELITHIASIS; DISEASE SEVERITY; ENTERITIS; FATTY LIVER; HEPATOBILIARY SYSTEM; HUMAN; LIVER DISEASE; LIVER TOXICITY; PATHOGENESIS; PORTAL VEIN THROMBOSIS; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; RISK FACTOR;

EID: 84858305511     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2012/642923     Document Type: Review

References (92)

1. Navaneethan U., Shen B., Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease Inflammatory Bowel Diseases 2010 16 9 1598 1619
2. Greenstein A. J., Janowitz H. D., Sachar D. B., The extra intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients Medicine 1976 55 5 401 412
3. Wiesner R. H., Grambsch P. M., Dickson E. R., Ludwig J., MacCarty R. L., Hunter E. B., Fleming T. R., Fisher L. D., Beaver S. J., LaRusso N. F., Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis Hepatology 1989 10 4 430 436 (Pubitemid 19255462)
4. Faubion W. A., Loftus E. V., Sandborn W. J., Freese D. K., Perrault J., Pediatric PSC-IBD: a descriptive report of associated inflammatory bowel disease among pediatric patients with PSC Journal of Pediatric Gastroenterology and Nutrition 2001 33 3 296 300 (Pubitemid 32947333)
5. Olsson R., Danielsson A., Jarnerot G., Lindstrom E., Loof L., Rolny P., Ryden B. O., Tysk C., Wallerstedt S., Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis Gastroenterology 1991 100 5 I 1319 1323
6. Bernstein C. N., Blanchard J. F., Rawsthorne P., Yu N., The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study American Journal of Gastroenterology 2001 96 4 1116 1122 (Pubitemid 32319146)
7. Smith M. P., Loe R. H., Sclerosing cholangitis. Review of recent case reports and associated diseases and four new cases The American Journal of Surgery 1965 110 2 239 246
8. Lee Y. M., Kaplan M. M., Primary sclerosing cholangitis New England Journal of Medicine 1995 332 14 924 933
9. Broomé U., Bergquist A., Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer Seminars in Liver Disease 2006 26 1 31 41 (Pubitemid 43320725)
10. Farrant J. M., Doherty D. G., Donaldson P. T., Vaughan R. W., Hayllar K. M., Welsh K. I., Eddleston A. L. W. F., Williams R., Amino acid substitutions at position 38 of the DR polypeptide confer susceptibility to and protection from primary sclerosing cholangitis Hepatology 1992 16 2 390 395
11. Olerup O., Olsson R., Hultcrantz R., Broome U., HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis Gastroenterology 1995 108 3 870 878
12. Mulder A. H. L., Horst G., Haagsma E. B., Kleibeuker J. H., Kallenberg C. G. M., Anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver disease Advances in Experimental Medicine and Biology 1993 336 545 548 (Pubitemid 24004986)
13. Bansi D. S., Fleming K. A., Chapman R. W., Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass Gut 1996 38 3 384 389 (Pubitemid 26074319)
14. Terjung B., Spengler U., Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases Clinical Reviews in Allergy and Immunology 2005 28 2 115 133 (Pubitemid 41264858)
15. Terjung B., Spengler U., Sauerbruch T., Worman H. J., 'Atypical p-ANCA' in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines Gastroenterology 2000 119 2 310 322 (Pubitemid 30621981)
16. Loftus E. V., Harewood G. C., Loftus C. G., Tremaine W. J., Harmsen W. S., Zinsmeister A. R., Jewell D. A., Sandborn W. J., PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis Gut 2005 54 1 91 96 (Pubitemid 40007225)
17. Lundqvist K., Broomé U., Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study Diseases of the Colon and Rectum 1997 40 4 451 456 (Pubitemid 27172624)
18. Joo M., Abreu-E-Lima P., Farraye F., Smith T., Swaroop P., Gardner L., Lauwers G. Y., Odze R. D., Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study American Journal of Surgical Pathology 2009 33 6 854 862
19. Rasmussen H. H., Fallingborg J. F., Mortensen P. B., Vyberg M., Tage-Jensen U., Rasmussen S. N., Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease Scandinavian Journal of Gastroenterology 1997 32 6 604 610 (Pubitemid 27314273)
20. Talwalkar J. A., Lindor K. D., Primary sclerosing cholangitis Inflammatory Bowel Diseases 2005 11 1 62 72 (Pubitemid 40340258)
21. Fulcher A. S., Turner M. A., Franklin K. J., Shiffman M. L., Sterling R. K., Luketic V. A. C., Sanyal A. J., Primary sclerosing cholangitis: evaluation with MR cholangiographya case-control study Radiology 2000 215 1 71 80 (Pubitemid 30190513)
22. Angulo P., Pearce D. H., Johnson C. D., Henry J. J., LaRusso N. F., Petersen B. T., Lindor K. D., Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis Journal of Hepatology 2000 33 4 520 527
23. Moff S. L., Kamel I. R., Eustace J., Lawler L. P., Kantsevoy S., Kalloo A. N., Thuluvath P. J., Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography Gastrointestinal Endoscopy 2006 64 2 219 223 (Pubitemid 44062484)
24. Berstad A. E., Aabakken L., Smith H. J., Aasen S., Boberg K. M., Schrumpf E., Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis Clinical Gastroenterology and Hepatology 2006 4 4 514 520
25. Textor H. J., Flacke S., Pauleit D., Keller E., Neubrand M., Terjung B., Gieseke J., Scheurlen C., Sauerbruch T., Schild H. H., Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography Endoscopy 2002 34 12 984 990 (Pubitemid 35446329)
26. Burak K. W., Angulo P., Lindor K. D., Is there a role for liver biopsy in primary sclerosing cholangitis? American Journal of Gastroenterology 2003 98 5 1155 1158 (Pubitemid 36733781)
27. Bergquist A., Ekbom A., Olsson R., Kornfeldt D., Lf L., Danielsson., Hultcrantz R., Lindgren S., Prytz H., Sandberg-Gertzén H., Almer S., Granath F., Broomé U., Hepatic and extrahepatic malignancies in primary sclerosing cholangitis Journal of Hepatology 2002 36 3 321 327 (Pubitemid 34194790)
28. Fevery J., Verslype C., Lai G., Aerts R., Van Steenbergen W., Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis Digestive Diseases and Sciences 2007 52 11 3123 3135 (Pubitemid 47512534)
29. Kim W. R., Therneau T. M., Wiesner R. H., Poterucha J. J., Benson J. T., Malinchoc M., Larusso N. F., Lindor K. D., Dickson E. R., A revised natural history model for primary sclerosing cholangitis Mayo Clinic Proceedings 2000 75 7 688 694 (Pubitemid 30441497)
30. Lindor K. D., Ursodiol for primary sclerosing cholangitis New England Journal of Medicine 1997 336 10 691 695 (Pubitemid 27102683)
31. Feldstein A. E., Perrault J., El-Youssif M., Lindor K. D., Freese D. K., Angulo P., Primary sclerosing cholangitis in children: a long-term follow-up study Hepatology 2003 38 1 210 217 (Pubitemid 36775813)
32. Tung B. Y., Emond M. J., Haggitt R. C., Bronner M. P., Kimmey M. B., Kowdley K. V., Brentnall T. A., Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis Annals of Internal Medicine 2001 134 2 89 95 (Pubitemid 32096335)
33. Graziadei I. W., Wiesner R. H., Marotta P. J., Porayko M. K., Eileen Hay J., Charlton M. R., Poterucha J. J., Rosen C. B., Gores G. J., LaRusso N. E., Krom R. A. F., Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis Hepatology 1999 30 5 1121 1127 (Pubitemid 29510847)
34. Graziadei I. W., Wiesner R. H., Batts K. P., Marotta P. J., Larusso N. F., Porayko M. K., Eileen Hay J., Gores G. J., Charlton M. R., Ludwig J., Poterucha J. J., Steers J. L., Krom R. A. F., Recurrence of primary sclerosing cholangitis following liver transplantation Hepatology 1999 29 4 1050 1056 (Pubitemid 29168735)
35. Angulo P., Maor-Kendler Y., Lindor K. D., Small-duct primary sclerosing cholangitis: a long-term follow-up study Hepatology 2002 35 6 1494 1500 (Pubitemid 34966904)
36. Wee A., Ludwig J., Coffey R. J. Jr., LaRusso N. F., Wiesner R. H., Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis Human Pathology 1985 16 7 719 726 (Pubitemid 15070245)
37. Bjrnsson E., Olsson R., Bergquist A., Lindgren S., Braden B., Chapman R. W., Boberg K. M., Angulo P., The natural history of small-duct primary sclerosing cholangitis Gastroenterology 2008 134 4 975 980 (Pubitemid 351451987)
38. Gregorio G. V., Portmann B., Karani J., Harrison P., Donaldson P. T., Vergani D., Mieli-Vergani G., Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study Hepatology 2001 33 3 544 553 (Pubitemid 32185215)
39. Woodward J., Neuberger J., Autoimmune overlap syndromes Hepatology 2001 33 4 994 1002 (Pubitemid 32246651)
40. Floreani A., Rizzotto E. R., Ferrara F., Carderi I., Caroli D., Blasone L., Baldo V., Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome American Journal of Gastroenterology 2005 100 7 1516 1522 (Pubitemid 41032356)
41. Abdo A. A., Bain V. G., Kichian K., Lee S. S., Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome Hepatology 2002 36 6 1393 1399 (Pubitemid 35403530)
42. Hill G. L., Mair W. S. J., Goligher J. C., Gallstones after ileostomy and ileal resection Gut 1975 16 12 932 936
43. Whorwell P. J., Hawkins R., Dewbury K., Wright R., Ultrasound survey of gallstones and other hepatobiliary disorders in patients with Crohn's disease Digestive Diseases and Sciences 1984 29 10 930 933 (Pubitemid 14021797)
44. Lorusso D., Leo S., Mossa A., Misciagna G., Guerra V., Cholelithiasis in inflammatory bowel disease. A case-control study Diseases of the Colon and Rectum 1990 33 9 791 794 (Pubitemid 20308169)
45. Lapidus A., Bngstad M., Astrm M., Muhrbeck O., The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease American Journal of Gastroenterology 1999 94 5 1261 1266 (Pubitemid 29214639)
46. Bargiggia S., Maconi G., Elli M., Molteni P., Ardizzone S., Parente F., Todaro I., Greco S., Manzionna G., Porro G. B., Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center Journal of Clinical Gastroenterology 2003 36 5 417 420 (Pubitemid 36459139)
47. Fraquelli M., Losco A., Visentin S., Cesana B. M., Pometta R., Colli A., Conte D., Gallstone disease and related risk factors in patients with Crohn disease: analysis of 330 consecutive cases Archives of Internal Medicine 2001 161 18 2201 2204 (Pubitemid 32905000)
48. Parente F., Pastore L., Bargiggia S., Cucino C., Greco S., Molteni M., Ardizzone S., Porro G. B., Sampietro G. M., Giorgi R., Moretti R., Gallus S., Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study Hepatology 2007 45 5 1267 1274 (Pubitemid 46775790)
49. Damio A. O. M. C., Sipahi A. M., Vezozzo D. P., Gonalves P. L., Fukui P., Laudanna A. A., Gallbladder hypokinesia in Crohn's disease Digestion 1997 58 5 458 463 (Pubitemid 27445614)
50. Annese V., VanTrappen G., Hutchinson R., Gall stones in Crohn's disease: another hypothesis Gut 1994 35 11 1676 (Pubitemid 24339280)
51. Dowling R. H., Bell G. D., White J., Lithogenic bile in patients with ileal dysfunction Gut 1972 13 6 415 420
52. Brink M. A., Slors J. F. M., Keulemans Y. C. A., Mok K. S., De Waart D. R., Carey M. C., Groen A. K., Tytgat G. N. J., Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease Gastroenterology 1999 116 6 1420 1427 (Pubitemid 29258891)
53. Taffet S. L., Das K. M., Sulfasalazine. Adverse effects and desensitization Digestive Diseases and Sciences 1983 28 9 833 842 (Pubitemid 13051918)
54. Teo L., Tan E., Sulphasalazine-induced DRESS Singapore Medical Journal 2006 47 3 237 239 (Pubitemid 43384841)
55. Rachmilewitz D., Barbier F., Defrance P., De Reuck M., Devis G., DeVos M., Elewaut A., Potvin P. H., Rutgeerts P., Vanheuverzwyn R., Van Trappen G., Bigard M., Camatte R., Cerf M., Colin R., Cortot A., Coumaros D., Gastard J., Labayle D., Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial British Medical Journal 1989 298 6666 82 86 (Pubitemid 19032930)
56. Hautekeete M. L., Bourgeois N., Potvin P., Duville L., Reynaert H., Devis G., Adler M., Kloppel G., Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine Gastroenterology 1992 103 6 1925 1927
57. Stoschus B., Meybehm M., Spengler U., Scheurlen C., Sauerbruch T., Cholestasis associated with mesalazine therapy in a patient with Crohn's disease Journal of Hepatology 1997 26 2 425 428 (Pubitemid 27077444)
58. Nahon S., Cadranel J. F., Chazouilleres O., Biour M., Jouannaud V., Marteau P., Liver and inflammatory bowel disease Gastroenterologie Clinique et Biologique 2009 33 5 370 381
59. Deltenre P., Berson A., Marcellin P., Degott C., Biour M., Pessayre D., Mesalazine (5-aminosalicylic acid) induced chronic hepatitis Gut 1999 44 6 886 888 (Pubitemid 29244228)
60. Tiede I., Fritz G., Strand S., Poppe D., Dvorsky R., Strand D., Lehr H. A., Wirtz S., Becker C., Atreya R., Mudter J., Hildner K., Bartsch B., Holtmann M., Blumberg R., Walczak H., Iven H., Galle P. R., Ahmadian M. R., Neurath M. F., CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes Journal of Clinical Investigation 2003 111 8 1133 1145 (Pubitemid 36519931)
61. Dubinsky M. C., Yang H., Hassard P. V., Seidman E. G., Kam L. Y., Abreu M. T., Targan S. R., Vasiliauskas E. A., 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease Gastroenterology 2002 122 4 904 915 (Pubitemid 34267273)
62. Cuffari C., Hunt S., Bayless T., Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease Gut 2001 48 5 642 646 (Pubitemid 32378583)
63. Cuffari C., Théort Y., Latour S., Seidman G., 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity Gut 1996 39 3 401 406 (Pubitemid 26338529)
64. Colombel J., Ferrari N., Debuysere H., Marteau P., Gendre J., Bonaz B., Soulé J. C., Modigliani R., Touze Y., Catala P., Libersa C., Broly F., Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy Gastroenterology 2000 118 6 1025 1030 (Pubitemid 30346978)
65. Deleve L. D., Wang X., Kuhlenkamp J. F., Kaplowitz N., Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease Hepatology 1996 23 3 589 599 (Pubitemid 26087175)
66. Russmann S., Zimmermann A., Krhenbhl S., Kern B., Reichen J., Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis European Journal of Gastroenterology and Hepatology 2001 13 3 287 290 (Pubitemid 32205420)
67. Daniel F., Cadranel J. F., Seksik P., Cazier A., Van Huyen J. P. D., Ziol M., Coutarel P., Loison P., Jian R., Marteau P., Azathioprine induced nodular regenerative hyperplasia in IBD patients Gastroenterologie Clinique et Biologique 2005 29 5 600 603 (Pubitemid 40825163)
68. Gisbert J. P., Luna M., Gonzlez-Lama Y., Pousa I. D., Velasco M., Moreno-Otero R., Maté J., Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients Inflammatory Bowel Diseases 2007 13 9 1106 1114 (Pubitemid 47402594)
69. Romagnuolo J., Sadowski D. C., Lalor E., Jewell L., Thomson A. B. R., Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity Canadian Journal of Gastroenterology 1998 12 7 479 483 (Pubitemid 28495463)
70. Shorey J., Schenker S., Suki W. N., Combes B., Hepatotoxicity of mercaptopurine Archives of Internal Medicine 1968 122 1 54 58
71. Bertino J. R., The mechanism of action of the folate antagonists in man Cancer Research 1963 23 1286 1306
72. Kremer J. M., Galivan J., Streckfuss A., Kamen B., Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates Arthritis and Rheumatism 1986 29 7 832 835 (Pubitemid 16072880)
73. Sandborn W. J., A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate American Journal of Gastroenterology 1996 91 3 423 433 (Pubitemid 126733803)
74. Germano V., Diamanti A. P., Baccano G., Natale E., Muda A. O., Priori R., Valesini G., Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis Annals of the Rheumatic Diseases 2005 64 10 1519 1520 (Pubitemid 41623873)
75. Jrnerot G., Hertervig E., Friis-Liby I., Blomquist L., Karlén P., Grnn C., Vilien M., Strm M., Danielsson A., Verbaan H., Hellstrm P. M., Magnuson A., Curman B., Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study Gastroenterology 2005 128 7 1805 1811 (Pubitemid 40824691)
76. Jarrett S. J., Cunnane G., Conaghan P. G., Bingham S. J., Buch M. H., Quinn M. A., Emery P., Anti-tumor necrosis factor- therapy-induced vasculitis: case series Journal of Rheumatology 2003 30 10 2287 2291 (Pubitemid 37221866)
77. Ueno Y., Tanaka S., Shimamoto M., Miyanaka Y., Hiyama T., Ito M., Kitadai Y., Yoshihara M., Sumii M., Chayama K., Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B Digestive Diseases and Sciences 2005 50 1 163 166 (Pubitemid 40379157)
78. Esteve M., Saro C., Gonzlez-Huix F., Suarez F., Forné M., Viver J. M., Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis Gut 2004 53 9 1363 1365 (Pubitemid 39120128)
79. Guidotti L. G., Chisari F. V., Noncytolytic control of viral infections by the innate and adaptive immune response Annual Review of Immunology 2001 19 65 91 (Pubitemid 32368030)
80. Herbein G., O'Brien W. A., Tumor necrosis factor (TNF)- and TNF receptors in viral pathogenesis Proceedings of the Society for Experimental Biology and Medicine 2000 223 3 241 257 (Pubitemid 30337778)
81. Biancone L., Pavia M., Del Vecchio Blanco G., D'Inc R., Castiglione F., De Nigris F., Doldo P., Cosco C., Vavassori P., Bresci G. P., Arrigoni A., Cadau G., Monteleone I., Rispo A., Fries W., Mallardi B., Sturniolo G. C., Pallone F., Hepatitis B and C virus infection in Crohn's disease Inflammatory Bowel Diseases 2001 7 4 287 294 (Pubitemid 33062093)
82. Nathan D. M., Angus P. W., Gibson P. R., Hepatitis B and C virus infections and anti-tumor necrosis factor- therapy: guidelines for clinical approach Journal of Gastroenterology and Hepatology 2006 21 9 1366 1371 (Pubitemid 44154702)
83. Miehsler W., Reinisch W., Valic E., Osterode W., Tillinger W., Feichtenschlager T., Grisar J., Machold K., Scholz S., Vogelsang H., Novacek G., Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004 53 4 542 548 (Pubitemid 38372979)
84. Jackson L. M., O'Gorman P. J., O'Connell J., Cronin C. C., Cotter K. P., Shanahan F., Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and Factor V Leiden Monthly Journal of the Association of Physicians 1997 90 3 183 188 (Pubitemid 27122556)
85. Baker M. E., Remzi F., Einstein D., Oncel M., Herts B., Remer E., Fazio V., CT depiction of portal vein thrombi after creation of ileal pouch-anal anastomosis Radiology 2003 227 1 73 79 (Pubitemid 36384182)
86. Remzi F. H., Fazio V. W., Oncel M., Baker M. E., Church J. M., Ooi B. S., Connor J. T., Preen M., Einstein D., Portal vein thrombi after restorative proctocolectomy Surgery 2002 132 4 655 662 (Pubitemid 35247329)
87. Ball C. G., MacLean A. R., Buie W. D., Smith D. F., Raber E. L., Portal vein thrombi after ileal pouch-anal anastomosis: its incidence and association with pouchitis Surgery Today 2007 37 7 552 557 (Pubitemid 46998952)
88. Vassiliadis T., Mpoumponaris A., Giouleme O., Hatzidakis A., Patsiaoura K., Zezos P., Vakalopoulou S., Kargiotis K., Gkisakis D., Katsinelos P., Evgenidis N., Late onset ulcerative colitis complicating a patient with Budd-Chiari syndrome: a case report and review of the literature European Journal of Gastroenterology and Hepatology 2009 21 1 109 113
89. Socha P., Ryzko J., Janczyk W., Dzik E., Iwanczak B., Krzesiek E., Hepatic vein thrombosis as a complication of ulcerative colitis in a 12-year-old patient Digestive Diseases and Sciences 2007 52 5 1293 1298 (Pubitemid 46626181)
90. Spina L., Saibeni S., Battaglioli T., Peyvandi F., De Franchis R., Vecchi M., Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia American Journal of Gastroenterology 2005 100 9 2036 2041
91. Riegler G., D'Inc R., Sturniolo G. C., Corrao G., Del Vecchio Blanco C., Di Leo V., Carrat R., Ingrosso M., Pelli M. A., Morini S., Valpiani D., Cantarini D., Usai P., Papi C., Caprilli R., Hepatobiliary alterations in patients with inflammatory bowel disease: a multicenter study Scandinavian Journal of Gastroenterology 1998 33 1 93 98 (Pubitemid 28114076)
92. Callen J. P., Soderstrom R. M., Granulomatous hepatitis associated with salicylazosulfapyridine therapy Southern Medical Journal 1978 71 9 1159 1160 (Pubitemid 9042580)